Middle East and Africa Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Market Outline: Middle East and Africa Swine Vaccines Market

Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy.

Market Dynamics: Middle East and Africa Swine Vaccines Market

Drivers

• High demand for healthy pork meat and rise in pork meat production
• Rise in prevalence of various infectious and foodborne diseases and expansion of business by the market players
• Grow in adoption of newer vaccines and development in economic growth

Restraints

• Stringent regulatory policies for the swine vaccine approval
• Adverse effects such as allergies associated with the vaccines
• High cost of vaccines and lack of awareness about the swine diseases in underdeveloped countries

Market Scope: Middle East and Africa Swine Vaccines Market

Middle East and Africa swine vaccines market is segmented on the basis of vaccine type, disease type, distribution channel, and country

Based on the vaccine type, Middle East and Africa swine vaccines market is segmented into the following

• Inactivated Vaccines
• Recombinant vaccines
• Live attenuated vaccines
• DNA vaccines
• Subunit vaccines
• Others

Based on the disease type, Middle East and Africa swine vaccines market is segmented into the following

• Viral Infections
• Bacterial Infections
• Parasitic Infection
• Fungal Infections
• Others

Based on the distribution channel, Middle East and Africa swine vaccines market is segmented into the following:

• Veterinary Hospitals
• Veterinary Pharmacies
• Online Pharmacies

Based on the country, Middle East and Africa swine vaccines market is segmented into the following:

• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

Competition Assessment: Middle East and Africa Swine Vaccines Market

Some of the players in the Middle East and Africa swine vaccines market include:

• Zoetis (Pfizer, Inc.) (U.S.)
• Merck & Co. Inc. (U.S)
• Virbac S.A. (France)
• Boehringer Ingelheim Vetmedica (Germany)
• Elanco (U.S.)
• Bayer Animal Health (Germany)
• Ceva Sante Animale (France)

Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies and regulatory framework
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

---

Location

GEOGRAPHY